Cargando…
Botulinum toxin A in the treatment of Raynaud's phenomenon: a systematic review
INTRODUCTION: The management of Raynaud's phenomenon in its most severe form is challenging, and current medical and surgical treatment methods frequently do not lead to optimal symptom control and prevention of ischemic complications. The aim of the study was to critically evaluate all existin...
Autores principales: | Żebryk, Paweł, Puszczewicz, Mariusz J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4947604/ https://www.ncbi.nlm.nih.gov/pubmed/27478469 http://dx.doi.org/10.5114/aoms.2015.48152 |
Ejemplares similares
-
Botulinum toxin in the treatment of Raynaud phenomenon in patients with systemic sclerosis: a systemic review
por: Cai, Ruyi, et al.
Publicado: (2022) -
Use of Botulinum Toxin A to Treat Chemotherapy-Induced Raynaud’s Phenomenon
por: Potluri, Thrisha K, et al.
Publicado: (2021) -
Improvement of pterygium inversum unguis and Raynaud phenomenon with interdigital botulinum toxin injections
por: Kim, Daniel J., et al.
Publicado: (2022) -
Efficacy of botulinum toxin type A injection for Raynaud’s phenomenon and digital ulcers in patients with systemic sclerosis
por: Jokar, Mohammad Hassan, et al.
Publicado: (2022) -
Botulinum toxin type A in the treatment of Raynaud’s phenomenon: A three-year follow-up study
por: Medina, Susana, et al.
Publicado: (2018)